Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
NetScientific PLC (GB:EMVC)
LSE:EMVC
Holding GB:EMVC?
Track your performance easily
EMVC Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range44.00p - 80.50p
Previous Close49p
Volume15.48K
Average Volume (3M)27.45K
Market Cap
£11.73M
Enterprise Value11.54M
Total Cash (Recent Filing)£852.00K
Total Debt (Recent Filing)£1.25M
Price to Earnings (P/E)―
Beta0.35
Next Earnings
Mar 26, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.13
Shares Outstanding23,945,828
10 Day Avg. Volume33,029
30 Day Avg. Volume27,450
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)62.34
Price to Sales (P/S)8.48
Price to Cash Flow (P/CF)-3.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
NetScientific News
PremiumCompany Announcements
EMV Capital’s PDS Biotech Updates on Trials and Financials
PremiumCompany Announcements
EMV Capital’s PDS Biotech Updates on Trials and Finances
PremiumCompany Announcements
EMV Capital Executives Bolster Investment
PremiumCompany Announcements
EMV Capital Director Increases ShareholdingOptions Prices
Currently, No data available
---
Ownership Overview
EMVC FAQ
What was NetScientific PLC’s price range in the past 12 months?
NetScientific PLC lowest share price was 44.00p and its highest was 80.50p in the past 12 months.
What is NetScientific PLC’s market cap?
Currently, no data Available
When is NetScientific PLC’s upcoming earnings report date?
NetScientific PLC’s upcoming earnings report date is Mar 26, 2025 which is in 132 days.
How were NetScientific PLC’s earnings last quarter?
NetScientific PLC released its earnings results on Sep 30, 2024. The company reported -0.23p earnings per share for the quarter, missing the consensus estimate of N/A by -0.23p.
Is NetScientific PLC overvalued?
According to Wall Street analysts NetScientific PLC’s price is currently Overvalued.
Does NetScientific PLC pay dividends?
NetScientific PLC does not currently pay dividends.
What is NetScientific PLC’s EPS estimate?
NetScientific PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NetScientific PLC have?
NetScientific PLC has 23,945,827 shares outstanding.
What happened to NetScientific PLC’s price movement after its last earnings report?
NetScientific PLC reported an EPS of -0.23p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.905%.
Which hedge fund is a major shareholder of NetScientific PLC?
Currently, no hedge funds are holding shares in GB:EMVC
---
NetScientific Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Insider Transactions
Bought Shares
Worth £30.1K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-17.24%
12-Months-Change
Fundamentals
Return on Equity
-15.86%
Trailing 12-Months
Asset Growth
1.66%
Trailing 12-Months
Company Description
NetScientific PLC
NetScientific PLC is a transatlantic healthcare technology company. The group is focused on sourcing, funding and commercializing technologies and companies that have the potential to treat chronic disease and significantly improve the health and well-being of people. Its portfolio consists of WANDA Health, an analytics company that uses machine learning to derive a personalized risk score for Congestive Heart Failure patients, Glucosense a provider of a non-invasive glucose monitoring wearable device, Vortex Biosciences which is engaged in circulating tumor cell identification, selection and analysis for disease monitoring and personalized therapeutic prescribing, and Glycotest which provides non-invasive blood tests for liver cancers and fibrosis-cirrhosis.
---
Technical Analysis
---